Minocycline Sandoz 100 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

minocycline sandoz 100 mg film-coat. tabl.

sandoz sa-nv - minocycline hydrochloride dihydrate 115,85 mg - eq. minocycline 100 mg - film-coated tablet - 100 mg - minocycline hydrochloride 115.85 mg - minocycline

Akamin New Zealand - English - Medsafe (Medicines Safety Authority)

akamin

viatris limited - minocycline hydrochloride 100mg (as the dihydrate.) - capsule - 100 mg - active: minocycline hydrochloride 100mg (as the dihydrate.) excipient: gelatin magnesium stearate

Minocin SA 100 mg Modified Release Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

minocin sa 100 mg modified release capsules

meda health sales ireland limited - minocycline hydrochloride - capsule - 100 mg milligram(s) - tetracyclines; minocycline

Minocin SA 100 mg Modified Release Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

minocin sa 100 mg modified release capsules

mylan ire healthcare limited - minocycline hydrochloride - modified-release capsule, hard - 100 mg milligram(s) - tetracyclines; minocycline

AKAMIN 50 minocycline (as hydrochloride) 50mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

akamin 50 minocycline (as hydrochloride) 50mg tablet bottle

alphapharm pty ltd - minocycline hydrochloride dihydrate, quantity: 54 mg (equivalent: minocycline, qty 50 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; microcrystalline cellulose; sodium starch glycollate; sodium lauryl sulfate; titanium dioxide; indigo carmine; hypromellose; sunset yellow fcf; quinoline yellow; macrogol 400 - infections due to the following organisms, provided that they have been shown by bacteriological testing to be susceptible to minocycline: escherichia coli; enterobacter aerogenes; haemophilus influenzae; klebsiella and proteus. in addition, infections due to streptococcus pyogenes (group a beta-haemolytic) and streptococcus faecalis, however, because a large proportion of these organisms are resistant to tetracyclines, minocycline should be used only if the organisms have definitely been shown to be sensitive. tetracyclines, including minocycline, are not the drugs of choice in the treatment of staphylococcal infections. minocycline may be considered for the treatment of such infections only if other suitable agents are not available and the organism has been shown to be sensitive to minocycline. minocycline may be used in the treatment of tetracycline resistant acne.

MINOCYCLINE 50 MG Israel - English - Ministry of Health

minocycline 50 mg

rafa laboratories ltd - minocycline as hydrochloride - capsules - minocycline as hydrochloride 50 mg - minocycline - minocycline - treatment of infections caused by minocycline-sensitive micro-organisms including acne, gonorrhea and prophylaxis of asymptomatic meningococcal carrier.

MINOCYCLINE 100 MG Israel - English - Ministry of Health

minocycline 100 mg

rafa laboratories ltd - minocycline as hydrochloride - capsules - minocycline as hydrochloride 100 mg - minocycline - minocycline - treatment of infections caused by minocycline-sensitive micro-organisms including acne, gonorrhea and prophylaxis of asymptomatic meningococcal carrie.

MINOCYCLINE HYDROCHLORIDE capsule United States - English - NLM (National Library of Medicine)

minocycline hydrochloride capsule

zydus pharmaceuticals usa inc. - minocycline hydrochloride (unii: 0020414e5u) (minocycline - unii:fyy3r43wgo) - minocycline 50 mg - minocycline hydrochloride capsules usp are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox and tick fevers caused by rickettsiae. respiratory tract infections caused by mycoplasma pneumoniae . lymphogranuloma venereum caused by chlamydia trachomatis . psittacosis (ornithosis) due to chlamydophila psittaci . trachoma caused by chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis caused by chlamydia trachomatis . nongonococcal urethritis, endocervical, or rectal infections in adults caused by ureaplasma urealyticum or chlamydia trachomatis . relapsing fever due to borrelia recurrentis . chancroid caused by haemophilus ducreyi . plague due to yersinia pestis . tularemia due to francisella tularensis . cholera caused by vibrio cholerae . campylobacter fetus infections caused